Results 71 to 80 of about 1,696 (185)

Plasma Adsorption Perfusion (BR‐350) Versus Open Albumin Dialysis (OPAL) for Hyperbilirubinemia in Hepatic Failure in Cirrhotic Patients

open access: yesArtificial Organs, Volume 50, Issue 4, Page 610-624, April 2026.
The therapy with PAP using BR‐350 resulted in a significant decrease of bilirubin concentrations. The median relative reduction of bilirubin was comparable between PAP and OPAL (47% vs. 40%, p = 0.29). The crossover comparison between the single session of PAP using BR‐350 and OPAL revealed similar relative reduction rates of bilirubin.
Justa Friebus‐Kardash   +8 more
wiley   +1 more source

Immunmodulation und funktionale Charakterisierung der durch CytoSorb® hämadsorbierten Proteine auf den Schaden mikrovaskulärer Endothelzellen

open access: yes, 2022
Blutreinigungsverfahren werden in klinischen Studien angewandt, um Patienten unter anderem im septischen Schock zu behandeln. Dabei wird versucht über die Adsorption von Zytokinen und danger associated moleculare patterns (DAMPs) die Funktion der ...
Denzinger, Maximilian Tobias
core   +1 more source

Inflammatory Cytokines as Early Predictors of Weaning Failure From Extracorporeal Life Support

open access: yesArtificial Organs, Volume 50, Issue 2, Page 259-270, February 2026.
Levels of IL‐8 and IL‐6 and their dynamics are reliable early predictors of ECLS weaning failure. ABSTRACT Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available.
Kostiantyn Kozakov   +11 more
wiley   +1 more source

Supplementary Material for: Rapid and effective elimination of myoglobin with CytoSorb® hemoadsorber in patients with severe rhabdomyolysis

open access: yes, 2023
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibres by various causes, diagnosed by increased creatin kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury.
Fuchs M. (17290282)   +6 more
core   +1 more source

A New Apheresis Device for Antithrombotic Drug Removal during Off-Pump Coronary Artery Bypass Surgery

open access: yesMedicina, 2022
Background and Objectives: The hemoadsorption device CytoSorb® (CytoSorbents Inc., Princeton, NJ, USA) has been shown to efficiently remove ticagrelor from whole blood in vitro.
Helmut Mair   +7 more
doaj   +1 more source

Successful treatment of severe quetiapine intoxication with CytoSorb hemoadsorption

open access: yesJournal of Clinical Pharmacy and Therapeutics, 2022
While many drug poisonings are successfully treated with specific antidotes, intoxications with tricyclic antidepressants and/or atypical neuroleptics still represent a major challenge. Besides conventional approaches, a new hemoadsorption device might represent an opportunity for therapeutic detoxification.We report a 64-year-old female patient who ...
Caterina Reuchsel, Falk A. Gonnert
openaire   +2 more sources

Sequential Use of Extracorporeal Blood Purification for Refractory Septic Shock Followed by Rhabdomyolysis: A (First) Case Report

open access: yesCase Reports in Critical Care, Volume 2026, Issue 1, 2026.
Septic shock is associated with high mortality worldwide despite adequate treatment. Various blood purification techniques have been available on the market for several years, aiming to remove circulating inflammatory mediators and to attenuate life‐threatening cytokine storms.
Erich Moresco   +4 more
wiley   +1 more source

Cytosorb use in postoperative treatment of a patient with infective endocarditis [PDF]

open access: yesSerbian Journal of Anesthesia and Intensive Therapy, 2018
We report of a 39 years old male patient who was admitted to hospital for a surgical treatment of endocarditis of the prosthetic aortic valve. Just after surgery, he had developed a severe inflammatory response with acute kidney and liver injury. Because
Marković Dejan   +5 more
doaj  

In vitro binding of selected antimicrobial agents to Cytosorb hemoadsorbent

open access: yes, 2022
Sepsa je življenjsko ogrožajoča motnja v delovanju organov, ki nastane zaradi neustreznega odziva organizma na okužbo. V sistemski krvni obtok se sproščajo povečane količine mediatorjev vnetja.
Cink, Teja
core  

Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Complex cardiac surgery and prolonged cardiopulmonary bypass are associated with significant activation of the systemic inflammatory response system.
Marianne Alarie   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy